SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-16-027017
Filing Date
2016-03-08
Accepted
2016-03-08 08:29:18
Documents
64
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K snbp20151231_10k.htm 10-K 1205042
2 EXHIBIT 10.9 ex10-9.htm EX-10.9 122235
3 EXHIBIT 31.1 ex31-1.htm EX-31.1 15129
4 EXHIBIT 31.2 ex31-2.htm EX-31.2 15217
5 EXHIBIT 32.1 ex32-1.htm EX-32.1 5657
6 EXHIBIT 32.2 ex32-2.htm EX-32.2 5950
13 graph2.jpg GRAPHIC 11955
14 graph1.jpg GRAPHIC 12410
  Complete submission text file 0001437749-16-027017.txt   4822191

Data Files

Seq Description Document Type Size
7 EXHIBIT 101.INS snbp-20151231.xml EX-101.INS 705119
8 EXHIBIT 101.SCH snbp-20151231.xsd EX-101.SCH 46459
9 EXHIBIT 101.CAL snbp-20151231_cal.xml EX-101.CAL 36894
10 EXHIBIT 101.DEF snbp-20151231_def.xml EX-101.DEF 348032
11 EXHIBIT 101.LAB snbp-20151231_lab.xml EX-101.LAB 304800
12 EXHIBIT 101.PRE snbp-20151231_pre.xml EX-101.PRE 370284
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 352-745-7665
Sun BioPharma, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: UT | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55242 | Film No.: 161490352
SIC: 2834 Pharmaceutical Preparations